scispace - formally typeset
K

Kazuro Fujimoto

Researcher at Nagoya University

Publications -  63
Citations -  3226

Kazuro Fujimoto is an academic researcher from Nagoya University. The author has contributed to research in topics: Aorta & Heart failure. The author has an hindex of 21, co-authored 63 publications receiving 2984 citations. Previous affiliations of Kazuro Fujimoto include University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications

TL;DR: Smooth muscle cells were filtration seeded in the scaffolds and it was shown that both scaffolds supported cell adhesion and growth, with smooth muscle cells growing more extensively in the PEUU scaffold.
Journal ArticleDOI

Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix.

TL;DR: Electrospraying vascular smooth muscle cells (SMCs) concurrently with electrospinning a biodegradable, elastomeric poly(ester urethane)urea (PEUU) matrix embodies a novel tissue engineering approach that could be applied to fabricate high cell density elastic tissue mimetics, blood vessels or other cardiovascular tissues.
Journal ArticleDOI

Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium

TL;DR: The designed poly(NIPAAm-co-AAc- co-HEMAPTMC) hydrogel of this report may offer an attractive biomaterial-centered treatment option for ischemic cardiomyopathy.
Journal ArticleDOI

Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization.

TL;DR: This method to rapidly and efficiently integrate cells into a strong, compliant biodegradable tubular matrix represents a significant achievement as a tissue engineering approach for blood vessel replacement.
Journal ArticleDOI

Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.

TL;DR: The literature to date generally demonstrates acute functional benefits associated with biomaterial injection therapy across a broad variety of animal models and material compositions, and further functional improvements have been reported when cellular or pharmaceutical agents have been incorporated into the delivery system.